Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine Care

Arthritis Care and Research

Volumn 70, Issue 9, 2018, Pages 1312-1319

  Varnier, Giulia Camilla ^a   Rosina, Silvia ^a   Ferrari, Cristina ^a   Pistorio, Angela ^b   Consolaro, Alessandro ^a   Bovis, Francesca ^a   Dalprà, Sara ^a   Pilkington, Clarissa ^c   Maillard, Susan ^c   Civino, Adele ^d   Tsitsami, Elena ^e   de Inocencio, Jaime ^f   Jelusic, Marija ^g   Vojinovic, Jelena ^h   Espada, Graciela ⁱ   Makay, Balahan ^j   Katsicas, Maria Martha ^k   Pratsidou Gertsi, Polixeni ^l   Lazarevic, Dragana ^m   Rao, Anand Prahalad ⁿ   Marafon, Denise Pires ^o   Ruperto, Nicolino ^b   Martini, Alberto ^a   Ravelli, Angelo ^a   more..

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d VITO FAZZI HOSPITAL   (Italy)

^e AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g KBC Zagreb   (Croatia)

^h UNIVERSITY OF NI   (Serbia)

ⁱ HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^j DOKUZ EYLUL UNIVERSITY   (Turkey)

^k HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^l Aristotle University and Hippokration General Hospital   (Greece)

^m Institute of Radiology   (Serbia)

ⁿ MANIPAL HOSPITAL   (India)

^o BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHILDHOOD MYOSITIS ASSESSMENT SCALE; CLINICAL DECISION MAKING; CONSTRUCT VALIDITY; CONTENT VALIDITY; DISEASE ACTIVITY; DISEASE COURSE; FACE VALIDITY; FEMALE; HUMAN; INTERNAL CONSISTENCY; JUVENILE DERMATOMYOSITIS; MAJOR CLINICAL STUDY; MALE; MANUAL MUSCLE TESTING IN 8 MUSCLES; MUSCLE STRENGTH; MUSCULOSKELETAL DISEASE ASSESSMENT; PATIENT SATISFACTION; TEST RETEST RELIABILITY; ADOLESCENT; DERMATOMYOSITIS; PRESCHOOL CHILD; PROCEDURES; REPRODUCIBILITY; RHEUMATOLOGY; VALIDATION STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; MUSCLE STRENGTH; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY;

EID: 85045924853     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.23491     Document Type: Article

References (28)

1. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008;371:2201–12.
2. Rider LG, Lindsley CB, Miller FW. Juvenile dermatomyositis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, editors. Textbook of pediatric rheumatology. 7th ed. Philadelphia: Elsevier Saunders; 2016. p. 351–84.
3. Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, et al. US incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003;49:300–5.
4. Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol 1995;34:732–6.
5. Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis. Arthritis Care Res (Hoboken) 2011;63:S118–57.
6. Ravelli A, Ruperto N, Trail L, Felici E, Sala E, Martini A. Clinical assessment in juvenile dermatomyositis. Autoimmunity 2006;39:197–203.
7. Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Smith M, et al. Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford) 2009;48:134–9.
8. Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, et al. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004;50:1595–603.
9. Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. Arthritis Rheum 1999;42:2213–9.
10. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010;19:539–49.
11. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344–7.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403–7.
13. Ruperto N, Ravelli A, Pistorio A, Ferriani V, Calvo I, Ganser G, et al. The Provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Care Res (Hoboken) 2008;59:4–13.
14. Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken) 2010;62:63–72.
15. Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003;49:7–15.
16. Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies: development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 2004;43:49–54.
17. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761–9.
18. Landgraf JM, Abetz L, Ware JE. Child Health Questionnaire (CHQ): a user's manual. 1st ed. Boston: The Health Institute; 1996.
19. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198–9.
20. Bellamy N. Clinimetric concepts in outcome assessment: the OMERACT filter. J Rheumatol 1999;26:948–50.
21. McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40–66.
22. Dejo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials 1991;12 Suppl:142S–58S.
23. Franzblau A. Correlation coefficients. In: Hartcouts BW, editor. A primer of statistics for non-statisticians. New York: Harcourt Brace; 1958.
24. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297–334.
25. Brunner HI, Ravelli A. Developing outcome measures for paediatric rheumatic diseases. Best Pract Res Clin Rheumatol 2009;23:609–24.
26. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994.
27. Filocamo G, Consolaro A, Schiappapietra B, Ruperto N, Pistorio A, Solari N, et al. Parent and child acceptable symptom state in juvenile idiopathic arthritis. J Rheumatol 2012;39:856–63.
28. Cohen J. Statistical power analysis for the behavioural sciences. New York: Academic; 1977.